TABLE 2.
Inverse probability of treatment weighted baseline characteristics of the study cohort
| Characteristics | ACE | ARB | Beta Blocker | CCB | Thiazide Diuretic |
|---|---|---|---|---|---|
| Sex = Female (%) | 52.3 | 52.2 | 52.7 | 51.8 | 51.4 |
| AMI (%) | 2.7 | 2.4 | 2.6 | 2.7 | 2.8 |
| Diabetes (%) | 17.9 | 18.8 | 18.4 | 18.0 | 19.0 |
| Heart failure (%) | 3.8 | 3.6 | 3.8 | 4.0 | 4.6 |
| Stroke (%) | 8.8 | 8.7 | 9.1 | 8.7 | 9.2 |
| CKD (%) | 3.1 | 3.0 | 3.1 | 3.0 | 2.8 |
| BMI (mean) | 28.4 | 28.4 | 28.3 | 28.4 | 28.6 |
| Diastolic BP (mean) | 87.1 | 87.2 | 87.0 | 87.2 | 87.2 |
| Systolic BP (mean) | 154.2 | 154.1 | 154.1 | 154.2 | 154.4 |
| Age (mean) | 62.9 | 62.7 | 63.0 | 62.8 | 63.0 |
Note: For a given baseline variable, similar weighted rates or means across study arms suggests adequate adjustment for confounding by that variable.
Abbreviations: AMI, acute myocardial infarction; CKD, chronic kidney disease; BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate.